Literature DB >> 24828130

Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders.

Ann Maloney1, Eric O Mick, Jean Frazier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24828130      PMCID： PMC4137505          DOI： 10.1089/cap.2013.0143

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  14 in total

1.  Acute and long-term safety and tolerability of risperidone in children with autism.

Authors:  Michael G Aman; L Eugene Arnold; Christopher J McDougle; Benedetto Vitiello; Lawrence Scahill; Mark Davies; James T McCracken; Elaine Tierney; Patricia L Nash; David J Posey; Shirley Chuang; Andres Martin; Bhavik Shah; Nilda M Gonzalez; Naomi B Swiezy; Louise Ritz; Kathleen Koenig; James McGough; Jaswinder K Ghuman; Ronald L Lindsay
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-12       Impact factor: 2.576

2.  A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Authors:  M Campbell; L T Anderson; M Meier; I L Cohen; A M Small; C Samit; E J Sachar
Journal:  J Am Acad Child Psychiatry       Date:  1978

3.  Behavioral effects of haloperidol in young autistic children. An objective analysis using a within-subjects reversal design.

Authors:  I L Cohen; M Campbell; D Posner; A M Small; D Triebel; L T Anderson
Journal:  J Am Acad Child Psychiatry       Date:  1980

Review 4.  Pharmacotherapy to control behavioral symptoms in children with autism.

Authors:  Carolyn A Doyle; Christopher J McDougle
Journal:  Expert Opin Pharmacother       Date:  2012-05-03       Impact factor: 3.889

5.  Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Authors:  Sarah Shea; Atilla Turgay; Alan Carroll; Miklos Schulz; Herbert Orlik; Isabel Smith; Fiona Dunbar
Journal:  Pediatrics       Date:  2004-10-18       Impact factor: 7.124

6.  Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

Authors:  L T Anderson; M Campbell; D M Grega; R Perry; A M Small; W H Green
Journal:  Am J Psychiatry       Date:  1984-10       Impact factor: 18.112

7.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

Authors:  M G Aman; N N Singh; A W Stewart; C J Field
Journal:  Am J Ment Defic       Date:  1985-03

8.  A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design.

Authors:  H Naruse; M Nagahata; Y Nakane; K Shirahashi; M Takesada; K Yamazaki
Journal:  Acta Paedopsychiatr       Date:  1982-08

9.  A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

Authors:  C J McDougle; J P Holmes; D C Carlson; G H Pelton; D J Cohen; L H Price
Journal:  Arch Gen Psychiatry       Date:  1998-07

10.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245
View more
  3 in total

Review 1.  Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.

Authors:  Tatiana M Kazdoba; Prescott T Leach; Mu Yang; Jill L Silverman; Marjorie Solomon; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 2.  Aripiprazole for autism spectrum disorders (ASD).

Authors:  Lauren E Hirsch; Tamara Pringsheim
Journal:  Cochrane Database Syst Rev       Date:  2016-06-26

Review 3.  Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions.

Authors:  Christian Popow; Susanne Ohmann; Paul Plener
Journal:  Neuropsychiatr       Date:  2021-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.